DCF — COULEE MEDICAL CENTER
Enterprise Value: $-39.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-39.3M
Enterprise Value
$-12.8M
PV of Cash Flows
$-26.5M
PV of Terminal Value
$-42.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $34.8M | $-2.3M | -6.0% | $-3.7M | $-3.4M |
| Year 2 | $35.9M | $-2.0M | -5.0% | $-3.5M | $-2.9M |
| Year 3 | $36.9M | $-1.7M | -4.0% | $-3.2M | $-2.4M |
| Year 4 | $38.1M | $-1.5M | -4.0% | $-3.1M | $-2.1M |
| Year 5 | $39.2M | $-1.5M | -4.0% | $-3.1M | $-1.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-39.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$33.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.06980564915826175
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5